Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

538 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Surveillance of parapoxvirus among ruminants in Virginia and Connecticut.
Roess AA, McCollum AM, Gruszynski K, Zhao H, Davidson W, Lafon N, Engelmeyer T, Moyer B, Godfrey C, Kilpatrick H, Labonte A, Murphy J, Carroll DS, Li Y, Damon IK. Roess AA, et al. Among authors: godfrey c. Zoonoses Public Health. 2013 Dec;60(8):543-8. doi: 10.1111/zph.12036. Epub 2013 Feb 8. Zoonoses Public Health. 2013. PMID: 23398718
Reply to Suthar et al.
Wallis CL, Godfrey C, Fitzgibbon JE, Mellors JW. Wallis CL, et al. Among authors: godfrey c. J Infect Dis. 2019 Jan 29;219(4):673-674. doi: 10.1093/infdis/jiy558. J Infect Dis. 2019. PMID: 30307562 Free PMC article. No abstract available.
Comparison of the metabolic effects of ritonavir-boosted darunavir or atazanavir versus raltegravir, and the impact of ritonavir plasma exposure: ACTG 5257.
Ofotokun I, Na LH, Landovitz RJ, Ribaudo HJ, McComsey GA, Godfrey C, Aweeka F, Cohn SE, Sagar M, Kuritzkes DR, Brown TT, Patterson KB, Para MF, Leavitt RY, Villasis-Keever A, Baugh BP, Lennox JL, Currier JS; AIDS Clinical Trials Group (ACTG) A5257 Team. Ofotokun I, et al. Among authors: godfrey c. Clin Infect Dis. 2015 Jun 15;60(12):1842-51. doi: 10.1093/cid/civ193. Epub 2015 Mar 12. Clin Infect Dis. 2015. PMID: 25767256 Free PMC article. Clinical Trial.
Three-year safety and efficacy of vicriviroc, a CCR5 antagonist, in HIV-1-infected treatment-experienced patients.
Wilkin TJ, Su Z, Krambrink A, Long J, Greaves W, Gross R, Hughes MD, Flexner C, Skolnik PR, Coakley E, Godfrey C, Hirsch M, Kuritzkes DR, Gulick RM. Wilkin TJ, et al. Among authors: godfrey c. J Acquir Immune Defic Syndr. 2010 Aug;54(5):470-6. doi: 10.1097/qai.0b013e3181e2cba0. J Acquir Immune Defic Syndr. 2010. PMID: 20672447 Free PMC article. Clinical Trial.
538 results